GURUFOCUS.COM » STOCK LIST » Canada » XCNQ » Core One Labs Inc (XCNQ:COOL) » Definitions » Earnings per Share (Diluted)
Switch to:

Core One Labs (XCNQ:COOL) Earnings per Share (Diluted)

: C$-0.48 (TTM As of Sep. 2022)
View and export this data going back to 2011. Start your Free Trial

Core One Labs's Earnings per Share (Diluted) for the three months ended in Sep. 2022 was C$-0.04. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2022 was C$-0.48.

Core One Labs's EPS (Basic) for the three months ended in Sep. 2022 was C$-0.04. Its EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2022 was C$-0.48.

Core One Labs's EPS without NRI for the three months ended in Sep. 2022 was C$-0.04. Its EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2022 was C$-0.48.


Core One Labs Earnings per Share (Diluted) Historical Data

The historical data trend for Core One Labs's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Core One Labs Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Earnings per Share (Diluted)
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -18.24 -10.56 -15.36 -10.30 -2.57

Core One Labs Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Earnings per Share (Diluted) Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.39 0.03 -0.47 - -0.04

Competitive Comparison

For the Biotechnology subindustry, Core One Labs's Earnings per Share (Diluted), along with its competitors' market caps and Earnings per Share (Diluted) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Core One Labs Earnings per Share (Diluted) Distribution

For the Biotechnology industry and Healthcare sector, Core One Labs's Earnings per Share (Diluted) distribution charts can be found below:

* The bar in red indicates where Core One Labs's Earnings per Share (Diluted) falls in comparison to its industry or sector. The grey bar indicates the Earnings per Share (Diluted)'s extreme value range as defined by GuruFocus.



Core One Labs Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Core One Labs's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2021 is calculated as

Diluted Earnings Per Share (A: Dec. 2021 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-37.055-0)/14.420
=-2.57

Core One Labs's Earnings Per Share (Diluted) for the quarter that ended in Sep. 2022 is calculated as

Diluted Earnings Per Share (Q: Sep. 2022 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(-1.182-0)/31.343
=-0.04

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


Core One Labs  (XCNQ:COOL) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Core One Labs Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Core One Labs's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Core One Labs (XCNQ:COOL) Business Description

Core One Labs logo
Traded in Other Exchanges
Address
1199 West Hastings Street, Suite 800, Vancouver, BC, CAN, V6E 3T5
Core One Labs Inc is a psychedelic research and development life sciences enterprise focused on bringing psychedelic medicines to market through novel delivery systems and psychedelic assisted psychotherapy. The company intends to further develop and apply the technology to psychedelic compounds, such as psilocybin. The Company operates a virtual clinic that assesses patients for the appropriateness of treatment plans for the use of medical cannabis to treat their symptoms. The Company partners with physicians and Health Canada's licensed producers for the provision of treatments, fulfillment of prescriptions, and sale of related products. Geographically the company generates revenue from the United States.